PMID: 6986978Mar 15, 1980Paper

So-called "Lennert's lymphoma": is it a clinicopathologic entity?

Cancer
H KimH Rappaport

Abstract

In order to investigate the natural history of so-called "Lennert's lymphoma" and to reevaluate whether non-Hodgkin's lymphoma with a high content of epithelioid histiocytes represents a clinicopathologic entity, we reviewed the histopathologic and clinical features of 60 patients in whom pretreatment diagnostic tissues had shown a diffuse and florid epithelioid histiocytic reaction identical to that originally described by Lennert and Mestdagh. Our study indicates that so-called "Lennert's lymphoma" is a heterogeneous group of disorders, which, in our series, included Hodgkin's disease (27 patients), non-Hodgkin's lymphoma (24 patients), angioimmunoblastic lymphadenopathy (1 patient), and atypical lymphoepithelioid cell proliferations of uncertain etiology and pathogenesis (8 patients). Most of the patients with Hodgkin's disease had Stage I or II disease without B symptoms, whereas patients with non-Hodgkin's lymphoma usually had Stage III or IV disease, commonly with B symptoms. The median survival was 79 months in the Hodgkin's disease group, compared with 12 months in patients with non-Hodgkin's lymphoma (P less than 0.0001). In patients with atpical lymphoepithelioid cell proliferations, the survival pattern was unpredict...Continue Reading

References

Nov 1, 1977·American Journal of Clinical Pathology·M A KleinR S Neiman
Jun 1, 1978·Journal of Clinical Pathology·J B MacGillivray, W G Macintosh
Jul 1, 1976·American Journal of Clinical Pathology·J S Burke, J J Butler
Jan 2, 1975·The New England Journal of Medicine·R J Lukes, B H Tindle
May 23, 1975·Deutsche medizinische Wochenschrift·T Radaszkiewicz, K Lennert
Sep 1, 1974·Human Pathology·R F Dorfman, R Warnke
Oct 15, 1970·The New England Journal of Medicine·M E KadinR F Dorfman

❮ Previous
Next ❯

Citations

Nov 1, 1988·Cancer Metastasis Reviews·S WatanabeM Shimoyama
May 3, 2000·The British Journal of Dermatology·M BhushanR J Chalmers
Dec 16, 2000·The American Journal of Surgical Pathology·Y YamashitaN Mori
Dec 1, 1990·British Journal of Haematology·R M LowenthalG M Woods
Nov 1, 1987·The British Journal of Radiology·M P Williams, G R Cherryman
Nov 1, 1993·Journal of the American Academy of Dermatology·A KikuchiT Nishikawa
Oct 1, 1981·Journal of the American Academy of Dermatology·I ZamoraC H Hu
Nov 26, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ya-Ping ChenKung-Chao Chang
Jan 1, 1987·Journal of Comparative Pathology·H Platt
Apr 1, 1987·Journal of Surgical Oncology·K Dabski, H L Stoll
Mar 1, 1982·Histopathology·M Miettinen, K Franssila
Jan 1, 1986·Hematological Oncology·S Watanabe
Jan 1, 1986·Seminars in Surgical Oncology·M L Brecher
Nov 1, 1986·British Journal of Haematology·N T O'ConnorD Y Mason
Mar 1, 1985·Cancer·R M White, J W Patterson
Dec 1, 1981·The Journal of Laryngology and Otology·I M ZardawiN K Saha
May 1, 1982·Cancer·T V ColbyR A Warnke
Jul 15, 1983·Cancer·G J Ruiz-ArgüellesR Pérez-Tamayo
Sep 15, 1982·Cancer·D S KarcherB Detrick-Hooks
Feb 24, 2005·Clinical and Experimental Dermatology·C MassoneF Rongioletti
May 1, 1992·Ultrastructural Pathology·H OlivaH Battifora

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.